Point of Care Diagnostics 2010 and Beyond: Rapid Testing at a Crossroads
PDF Format
|
|
|
|
|
Published
: November 2009 |
|
No.of Pages : 300 |
| |
|
|
|
|
Price :
US$ 3,995.00 |
|
|
Site
License : US$ 7,990.00 |
|
|
|
|
|
|
As Kalorama Information's lead diagnostic analyst finds, the point of care concept is at a crossroads: the technologies needed to make rapid testing a reality are here. But is healthcare ready?
The drive for wellness and the attention surrounding healthcare reform will surely focus attention on rapid diagnostics. However, according to Shara Rosen, RT, M.B.A., there are many challenges which must be overcome for point of care solutions to fit, and those companies willing to pivot strategies and best adjust to changes in the healthcare marketplace may be rewarded.
This report, Point of Care Diagnostics 2010: Rapid Testing at a Crossroads represents the most current analysis of the role of Point of Care Diagnostics in today's in vitro industry. Other reports have looked at products, companies and market forecasts, as this report does. But in her analysis Shara Rosen takes a bold look into the markets, technologies, and trends in decentralized testing with a special focus on the economics of rapid test use in critical care and emergency medicine. The report includes:
-
Markets for POC Diagnostics (Diabetes, Cardiac markers, Clinical Chemistry/Critical Care, Hematology, Coagulation, Drugs of Abuse/Therapeutic Drug Monitoring, Infectious Diseases, Pharmacodiagnostics, Sepsis, Oncology, Women’s health / Pregnancy/Fertility)
By Venue Revenue Estimates for Hospital POC, Physician POC and Other Venue
Review of Products in the Market
Forecasts to 2013
Markets and Forecasts for Self-Testing (OTC)
The role of EMR in the Point of Care Market
Possible Effects of Healthcare Reform
POLs, Home Monitoring, Alternate Samples and Other Trends
Successful Strategies of POC Companies
Profiles of Over 100 Companies Competing in this Market
There are many factors in the growth of POC testing- increasing numbers of diagnosed diabetics, people with cardiovascular disease, and other chronic conditions. It is also expected to play a role in a trend in health care to evaluate provider organizations for quality in care delivery. While this quality imperative is most apparent in pay-for-performance systems, it also provides a framework by which public funds can be used more rationally. This is an especially relevant technology given the U.S. healthcare reform efforts.
All countries are feeling the brunt of aging populations and an increased burden of chronic disease management. Employers and insurance companies are interested in improving the health of customers, and there are some innovative tactics developing in this area. The report is conservative in its predictions and offers a calculated look into the future, based on events currently taking place.
The report offers a quantitative assessment of specific markets in US dollars for 2008 and forecasted out to 2013. These data are provided in order to set the status quo of tests and technologies. However the report concentrates on how these will impact the economics of healthcare over the near term and longer when possible.
As part of Kalorama Information's comprehensive coverage, the following companies are discussed:
-
23andMe
-
3M Health Care
-
77 Elektronika
-
A. Menarini
-
A/C Diagnostics
-
Abaxis, Inc.
-
Abbott Diagnostics
-
ABTECH Scientific
-
Accumetrics
-
ACIST Medical
-
Acrongenomics Inc.
-
Adeza Biomedical
-
ADIATEC
-
Aerscher Diagnostics
-
AgaMetrix, Inc.
-
Alfa Scientific
-
Alfa Wassermann
-
Alverix Inc.
-
American Bio Medica
-
Amic/Ortho
-
Amnisure International
-
Animas/J&J
-
ANP Technologies
-
Antigen Discovery Inc.
-
Apollo Hospitals
-
Arkray
-
Arrayit Diagnostics
-
AspenBio Pharma
-
Astron Clinica
-
AT First Diagnostic
-
Audit Diagnostics
-
Axis-Shield plc
-
Bayer Diabetes Care
-
Beckman Coulter
-
Becton Dickinson
-
Bedfont Scientific
-
Biohit Oy
-
BioIQ
-
bioLytical Labs
-
Biomagnetics Diagnostics
-
Biomerica, Inc.
-
bioMérieux
-
Bionime Corp.
-
Bio-Rad Laboratories
-
BIOSAFE Medical Technologies
-
Biosite/Inverness
-
Boditech Med
-
BodyTel Scientific
-
Branan Medical Corp
-
Burnet Institute
-
Calypte Biomedical
-
Careside Medical
-
Carolina Liquid Chemistries
-
Celerus Diagnostics
-
Chelsea Technologies
-
Chembio Diagnostic
-
Chempaq A/S
-
Chemtron Biotech
-
Cholestech Corp.
-
Claros Diagnostics
-
CLX Medical, Inc.
-
Combimatrix
-
Common Sense, Ltd.
-
Commonwealth Labs
-
Connectyx Technologies
-
ContraVac, Inc.
-
Decision Biomarkers
-
DexCom, Inc.
-
Diabetech, LP
-
Diabetes Sentry
-
Diaglobal GmbH
-
Diagnostic Devices
-
Diagnostics for All
-
Diagnostics for the Real World
-
Diazyme Laboratories
-
Digital Bio Tech
-
Diversa Limited
-
DNA Direct, Inc.
-
DNAFORM
-
DxNA
-
Echo Therapeutics
-
EKF-diagnostic GmbH
-
Enfora
-
Enigma Diagnostics
-
Enterix Inc.
-
Entra Health
-
Epocal, Inc.
-
EPS Bio Technology
-
ESA Biosciences
-
eScreen, Inc.
-
ExpressMD Solutions
-
EyeMarker Systems
-
Flexsite Diagnostics
-
Focus Diagnostics
-
Fora Care
-
GE Healthcare
-
GenBio
-
Gene Smart Wellness
-
Genexel-Sein Inc.
-
Gentag Inc.
-
Genzyme Diagnostics
-
Global Detection & Reporting
-
Glucometrics, Inc.
-
Google, Inc.
-
Guided Therapeutics
-
Hai Kang Life Corp.
-
Hain Lifescience GmbH
-
HandyLab, Inc.
-
HealthPia America
-
HealthPort
-
Helena Laboratories
-
Hema Diagnostic Systems
-
Hema Metrics
-
HemoCue AB
-
Hero Network Network
-
HMM GmbH
-
Hoana Medical
-
Home Access Health
-
Home Diagnostics
-
Horiba ABX
-
Idaho Technology
-
IDenta Corp
-
Identigene
-
IDEXX Laboratories
-
incentaHEALTH LLC
-
Innovative Biosensors
-
Instrumentation Laboratory
-
Insulet Corporation
-
Integrity Applications
-
Intel Corporation
-
International Technidyne
-
Inverness Medical Innovations
-
Knome
-
Lab Express
-
LifeAssays AB
-
Lifescan
-
LifeSign LLC
-
LifeStat
-
Lifestream Technologies, Inc.
-
Lifestyle Choices
-
Luminex
-
Luminous Medical
-
MACHEREY-NAGEL
-
Masimo Corp
-
Matritech
-
M-Biotech
-
Medical Automation Systems
-
MedMira Inc.
-
Medtronic Inc.
-
Menssana Research, Inc.
-
Meretek Diagnostics Inc.
-
Meridian Bioscience
-
Micromem Technologies
-
Micronics Inc.
-
MicroPhage, Inc.
-
MinuteClinic
-
Mitsubishi Kagaku Iatron
-
MP Biomedicals
-
Multilyte Limited
-
MycroLab Pty
-
Nanogen
-
Nanomix, Inc.
-
Nanosphere, Inc.
-
National Jewish Health
-
Navigenics, Inc.
-
Network Biosystems
-
Neuroptix Corp
-
Nihon Kohden
-
Noninvasive Medical Tech
-
Nova Biomedical
-
OPTI Medical Systems
-
OraSure Technologies
-
Orion Diagnostica
-
OrSense Ltd.
-
Ortho Clinical Diagnostics
-
OvumOptics, Inc.
-
Oxford Biosensors
-
Oxonica Diagnostics
-
Phadia AB
-
Philips Handheld Immunoassays
-
PlaCor, Inc.
-
PointCare Technologies
-
Polymedco
-
Practice Fusion
-
PreMD Inc.
-
PrimeraDx
-
Probe Scientific Ltd
-
Prometheus Laboratories
-
Psynomics
-
QBC Diagnostics
-
Qiagen
-
Q-linea
-
Quadraspec
-
QualSec, Inc
-
QuantRx Biomedical Corporation
-
Quidel Corp
-
Quotient Diagnostics
-
Radiometer A/S
-
Raman spectroscopy
-
Rapid Pathogen Screening
-
Rennesens GmbH
-
Response Biomedical
-
Rite Aid
-
Roche Diagnostics
-
Royal Philips Electronics
-
Safeway, Inc.
-
Screening Devices Canada
-
SEMOFS
-
Sentinel Bioactive Paper Network
-
SeraCare Life Sciences
-
Serotec
-
Siemens Healthcare Diagnostics
-
SIENCO
-
Smiths Detection
-
Smiths Medical MD
-
Soar BioDynamics
-
Solei Systems, Inc
-
Solianis Monitoring
-
SpectraScience, Inc.
-
Sphere Medical Ltd.
-
SpheroSense Technologies
-
Stanbio Laboratory
-
StatSure Diagnostic Systems
-
STD Test Express
-
STMicroelectronics
-
Synova Healthcare
-
Sysmex Corp
-
T2 Biosystems
-
Taidoc Technology
-
TelCare
-
Telus Corporation
-
Textronics, Inc.
-
Thermo Fisher Scientific
-
Tosoh Corp
-
Trinity Biotech
-
TwistDx, Ltd.
-
Tyrian Diagnostics
-
UnitedHealth Group
-
Veralight, Inc.
-
Veredus Laboratories
-
VeriChip Corporation
-
Via Medical Corp
-
Vital Diagnostics
-
Vivacta Limited
-
Walgreens
-
Wal-Mart Stores
-
Webahn Inc.
-
Ypsomed
|
|
TABLE OF CONTENTS :
CHAPTER ONE: EXECUTIVE SUMMARY
Scope and Methodology Size and Growth of the Market Market Trends
CHAPTER TWO: INTRODUCTION
Miniaturization, Digitization and Informatics The pros and cons of POC testing Point of View
CHAPTER THREE: ECONOMICS, EMR AND HEALTHCARE REFORM
Healthcare Reform POC and Clinical Outcomes Management POC’s Unmet Need
CHAPTER FOUR: TECHNOLOGY AND INDUSTRY TRENDS
Background The search for non-invasive tools Saliva Breath Optical Techniques Patch Technology Wearable Sensors/Textiles The Wireless Revolution Connectivity Imperative Lab-on-a chip
CHAPTER FIVE: VENUES FOR POC TESTING
POC Testing in the Hospital POL and Clinic Testing Retail Outlets Other Professional POC Venues - Workplace Testing and Home Visits Home Monitoring of Individuals with Chronic Diseases Self-Test Sector - OTC Tests
CHAPTER SIX: MARKET ANALYSIS
Market Overview Prognosis for POC growth Technological Challenges Market and Forecasts Self Testing/OTC Breakout of Non-Glucose Tests Professional POC Testing POC in world markets Europe Asia Rest of World United States Physician Office Labs United Kingdom HIV/AID Market for Rapid Flu Testin The Major Players Licenses and Distribution Agreements Struggling Competitors
CHAPTER SEVEN: POC TEST SEGMENTS
Diabetes Testing - Blood Glucose Monitoring (BGM) Blood Glucose Self-Testing Blood Glucose Testing by Professionals Diabetes Testing - Glycated Hemoglobin Cardiovascular Diagnostics Cardiac Markers (AMI enzymes) Cholesterol/Lipid Panels Clinical Chemistry/Critical Care Hemoglobin Testing for Anemia Hematology Coagulation Decentralized Coagulation testing - Professional Use Decentralized Coagulation Testing - OTC Drugs of Abuse/Therapeutic Drug Monitoring Allergy Infectious Diseases OTC Tests for Infectious Diseases Professional POC Tests for Infectious Diseases Pharmacodiagnostics Sepsis Oncology Bladder Cancer Colon Cancer Prostate Cancer Cervical Cancer Women’s Health / Pregnancy/Fertility Emerging Tests and Technologies Commercial Outlook
CHAPTER EIGHT: COMPANY PROFILES MAJOR COMPANIES
Abbott Diagnostics Diabetes Critical Care Hematology ARKRAY, Inc. Distribution News Product News Bayer Diabetes Care Beckman Coulter Inc. Becton, Dickinson and Company (BD) bioMerieux Inc. Bio-Rad Laboratories Inc. GE Healthcare Instrumentation Laboratory Inverness Medical Innovations Lifescan Inc. Nova Biomedical Ortho Clinical Diagnostics (OCD) Qiagen N.V. Quidel Corporation Radiometer A/S Roche Diagnostics Diabetes Cardiac Markers Clinical Chemistry Critical Care Siemens Healthcare Diagnostics Cardiac Markers Diabetes Care Blood Gases Urinalysis Sysmex Corporation TOSOH Corporation
‘New Frontier’ POC COMPANIES
3M Health Care 77 Elektronika Kft. Abaxis, Inc. A/C Diagnostics Accumetrics ACIST Medical Systems, Inc. AgaMetrix, Inc. Alfa Wassermann Diagnostic Technologies, LLC (AWDT) American Bio Medica Corp Audit Diagnostics Axis-Shield plc Biohit Oy BioIQ Biomerica, Inc. Biosite Incorporated B.R.A.H.M.S. AG Calypte Biomedical Corporation Chembio Diagnostic Systems, Inc. Chempaq A/S Cholestech Corporation Concateno plc DexCom, Inc. Diabetech, LP Diazyme Laboratories EKF-diagnostic GmbH ESA Biosciences Inc. Hain Lifescience GmbH HandyLab, Inc. Helena Laboratories USA Hema Diagnostic Systems (HDS) HemoCue AB HemoSense, Inc. Home Diagnostics, Inc. Horiba ABX S.A. Insulet Corporation International Technidyne Corp (ITC) Masimo Corporation Matritech Medical Automation Systems, Inc. MedMira Inc. Medtronic Inc. A. Menarini Diagnostics Meridian Bioscience MP Biomedicals LLC Nanosphere, Inc. OPTI Medical Systems, Inc. OraSure Technologies, Inc. Phadia AB Philips Handheld Immunoassays Polymedco, Inc. QBC Diagnostics, Inc. Response Biomedical Corp Serotec (AbD Serot Smiths Medical MD, Inc. (formerly Deltec, Inc.) Stanbio Laboratory Taidoc Technology Corp. Trinity Biotech plc Via Medical Corporation Vital Diagnostics
Other Players
Acrongenomics Inc. Alfa Scientific Designs, Inc. Amic AB Astron Clinica AspenBio Pharma, Inc. AT First Diagnostic, LLC bioLytical Laboratories Inc. Biomagnetics Diagnostics Corporation Bionime Corporation BodyTel Scientific, Inc. Burnet Institute Celerus Diagnostics Chelsea Technologies Group Ltd Claros Diagnostics CLX Medical, Inc. ContraVac, Inc. Decision Biomarkers Inc. Diabetes Sentry Products Inc. Diaglobal GmbH Diagnostic Devices, Inc. Diagnostics for All (DFA) Diagnostics for the Real World (DRW) Digital Bio Technology/ InCyto Diversa Limited (formerly Ambri Ltd.) DNAFORM DxNA Echo Therapeutics, Inc. (previously Sontra Medical) Enigma Diagnostics Limited Enterix Inc. Entra Health Systems Epocal, Inc. EUMED Biotechnology Co. Ltd. eScreen, Inc. EyeMarker Systems, Inc. Flexsite Diagnostics, Inc. Fora Care GenBio Gene Smart Wellness Gentag Inc. Glucometrics, Inc. Guided Therapeutics, Inc. Hai Kang Life Corporation HealthPia America Heidelberger-Medical-Marketing GmbH (HMM GmbH) Hema Metrics Hoana Medical, Inc. Idaho Technology, Inc. Identa Corporation dentigene Innovative Biosensors, Inc. Integrity Applications Ltd. Intel Corporation LifeAssays AB LifeSign LLC Lifestyle Choices Ltd Luminous Medical, Inc.: M-Biotech Menssana Research, Inc. Micromem Technologies Inc. Micronics Inc. MicroPhage, Inc. Multilyte Limited MycroLab Pty Ltd. Nanomix, Inc. National Jewish Health Network Biosystems Neuroptix Corporation Noninvasive Medical Technologies, Inc. OrSense Ltd. OvumOptics, Inc. Oxonica Diagnostics PlaCor, Inc. PointCare Technologies Probe Scientific Ltd Prometheus Laboratories Inc. Q-linea Quadraspec QualSec, Inc QuantRx Biomedical Corporation Quotient Diagnostics Rapid Pathogen Screening Rennesens GmbH Screening Devices Canada, Inc. Sentinel Bioactive Paper Network Sphere Medical Ltd. SIENCO Smiths Detection Solei Systems, Inc. Solianis Monitoring AG SpheroSense Technologies Inc. STD Test Express Surface Enhanced Micro Optical Fluidic Systems T2 Biosystems, Inc. TwistDx, Ltd. Veralight, Inc. Veredus Laboratories Pte VeriChip Corporation Vivacta Limited
LIST OF EXHIBITS CHAPTER ONE: EXECUTIVE SUMMARY
Table 1-1: Exchange Rate Fluctuations, 2005-2008 Table 1-2: POC Sales by Test Category (OTC and POC), Worldwide 2008-2013
CHAPTER FOUR: TECHNOLOGY AND INDUSTRY TRENDS
Table 4-1: Selected Non-Invasive Testing Innovations Table 4-2: Selected disease markers in exhaled breath Table 4-3: Selected POC Wireless Innovations, 2008-2009 Table 4-4: RALS connected POC systems, 2009 Table 4-5: Selected biochip and biosensor innovations, 2009
CHAPTER FIVE: VENUES FOR POC TESTING
Figure 5-1: Venues for POC Testing (Hospital, Physician, Other) Table 5-1: POC Test Sales in the Hospital Sector (Critical Care, Glucose, Cardiac Markers, Infectious Diseases, Coagulation, Hematology, Drugs of Abuse, Cholesterol, Pregnancy, Urinalysis), 2008 Table 5-2: POC Test Sales in the POL Sector (Glucose, Cholesterol, HbA1c, Coagulation, Hematology, Chemistry/Immunoassays, Infectious Diseases, Fecal Occult Blood, Pregnancy, Cardiac Markers, Oncology, Urinalysis, Drugs of Abuse), 2008 Table 5-3: Selected Small Footprint Chemistry Systems, 2009 Table 5-4: Selected Small Footprint Hematology Systems, 2009 Table 5-5: Selected New Small Footprint Immunoassay Systems, 2009 Table 5-6: POC Test Sales in Other Care Venues (Glucose, Cholesterol, Drugs of Abuse, Fecal Occult Blood, Infectious Diseases, Urinalysis, Coagulation), 2008 Table 5-7: Selected self-test innovations, 2008-2009
CHAPTER SIX: MARKET ANALYSIS
Table 6-1: OTC/Self Test Sales by Test Category (Glucose, Pregnancy, Coagulation, Fecal Occult Blood, Drugs of Abuse, HbA1c, HIV, Cholesterol, Other) Worldwide 2008 and 2013 Figure 6-1: Breakout of Non-Glucose Self-Testing Figure 6-2: Professional POC Testing Market by Test Category Table 6-2: Professional Point of Care Testing Market by Test Category (Glucose, Critical Care, Cardiac Markers, Infectious Diseases, Cholesterol/Lipids, Coagulation, Hematology, HbA1c, Chemistry/Immunoassays, Fecal Occult Blood, Drugs of Abuse, Pregnancy, Urinalysis, Onocology, Other) 2008 and 2013 Figure 6-3: Professional POC Testing Market by Test Category Table 6-3: POC Test Sales by Region (US, Europe, Asia, ROW), 2008-2013 Table 6-4: POC Test Revenues of Selected IVD Companies, $ million, estimated Table 6-5: Selected Market Expansion Deals in POC testing, 2008-2009
CHAPTER SEVEN: POC TEST SEGMENTS
Table 7-1: World Glucose Monitoring Sales, by Company, 2005 - 2008 Table 7-2: Selected Glucose Meter Innovations, 2008-2009 Table 7-3: Selected Wireless Enabled Blood Glucose Monitors, 2009 Table 7-4: Selected Continuous BGM Sales by Company, 2008 Table 7-5: Selected Continuous Blood Glucose Systems, 2009 Table 7-6: Glucose Meters that use GDH-PQQ technology Table 7-7: Selected POC HbA1c Devices, 2009 Table 7-8: Worldwide Sales, POC CVD markers (Cholesterol -Professional, Cholesterol OTC, AMI Enzymes), 2008-2013 Table 7-9: Selected POC Hematology Systems, 2009 Table 7-10: World POC Coagulation Sales(PT-Professional, PT OTC, ACT), 2008 (million) Table 7-11: Selected CLIA Waived PT Devices Table 7-12: Selected Rapid HIV Tests on the Market Table 7-13: Selected Rapid Infectious Disease Test Innovations Table 7-14: Selected Women’s Health OTC Tests Table 7-15: Selected POC Platform Innovations, 2008/2009
|
| |
| |
|
Site
License Price : US$ 7,990.00
|
|
Related tags :
Demand Forecast, Market, Market forecast, Market growth, Market Leaders, Market Share, Market Size, Research, Market Report, Report
|
| |
|
Custom Research :
If the above report doesn't have the business information
suitable for your business, we can provide custom
research that would be lucrative for your business or
enhance your profession. We leverage most comprehensive,
affordable, high-quality custom research which will
match the exact topic and specifications of your choice.
Please visit
http://www.bharatbook.com/general/customresearch.asp to make an enquiry. |
| |
Product
Id : 125048 |
| |
Kalorama Information |
|